Abstract
Background: Polymers are used in drug delivery systems to encapsulate and release the drug. Natural polymers have the advantages of biodegradability, biocompatibility, and recognizable biological moieties that maintain cellular functions as compared to synthetic polymers. Chitosan is a natural polycationic linear polysaccharide that originates from chitin. Its easy modification, release rate of drug, ability to cross-link with other polymers, gelling ability, immunostimulation, bioadhesion, biocompatibility, and biodegradability has increased its application in various drug delivery systems.
Objective: The objective of the present study is to overview the recent patents of the application of chitosan in various drug delivery systems and their use in the prevention of cancer and other ailments.
Methods: In this review, the patent application of chitosan in various drug delivery systems employed to cure mainly cancer has been covered with particular emphasis on their scientific impact and novelty.
Results: Chitosan has proved its potential as a polymer to control and target the drug at the site of action.
Conclusion: The potential of chitosan and its derivatives to deliver and target the drug may open new avenues for therapeutic interventions in different tumors.
Keywords: Cancer, chitosan, modification, novel drug delivery system, patent, polymer.
Recent Patents on Anti-Cancer Drug Discovery
Title:Chitosan - A Potential Polymer to Prepare Anticancer Drug Delivery Systems: Patent Review
Volume: 16 Issue: 2
Author(s): Priyanka Kriplani*Kumar Guarve
Affiliation:
- Guru Gobind Singh College of Pharmacy, Yamuna Nagar 135001, Haryana,India
Keywords: Cancer, chitosan, modification, novel drug delivery system, patent, polymer.
Abstract:
Background: Polymers are used in drug delivery systems to encapsulate and release the drug. Natural polymers have the advantages of biodegradability, biocompatibility, and recognizable biological moieties that maintain cellular functions as compared to synthetic polymers. Chitosan is a natural polycationic linear polysaccharide that originates from chitin. Its easy modification, release rate of drug, ability to cross-link with other polymers, gelling ability, immunostimulation, bioadhesion, biocompatibility, and biodegradability has increased its application in various drug delivery systems.
Objective: The objective of the present study is to overview the recent patents of the application of chitosan in various drug delivery systems and their use in the prevention of cancer and other ailments.
Methods: In this review, the patent application of chitosan in various drug delivery systems employed to cure mainly cancer has been covered with particular emphasis on their scientific impact and novelty.
Results: Chitosan has proved its potential as a polymer to control and target the drug at the site of action.
Conclusion: The potential of chitosan and its derivatives to deliver and target the drug may open new avenues for therapeutic interventions in different tumors.
Export Options
About this article
Cite this article as:
Kriplani Priyanka *, Guarve Kumar , Chitosan - A Potential Polymer to Prepare Anticancer Drug Delivery Systems: Patent Review, Recent Patents on Anti-Cancer Drug Discovery 2021; 16 (2) . https://dx.doi.org/10.2174/1574892816666210208230848
DOI https://dx.doi.org/10.2174/1574892816666210208230848 |
Print ISSN 1574-8928 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3970 |
Call for Papers in Thematic Issues
Novel anti-cancer drugs in photoimmunotherapy management: from bench to translational research
In recent years, traditional cancer treatments, such as surgery, chemotherapy, and radiation treatment, etc., may damage the pathological tissue and normal cells. The ideal tumor treatment should be noninvasive, eliminating the primary tumor, making the body produce systemic tumor-specific immunity, eliminating metastases, and having less /no side effects. Recent Patents ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
Current Cancer Drug Targets Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops
Current Signal Transduction Therapy Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
Anti-Cancer Agents in Medicinal Chemistry T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design Self-Assembly of DNA and Cell-Adhesive Proteins onto pH-Sensitive Inorganic Crystals for Precise and Efficient Transgene Delivery
Current Pharmaceutical Design Use of Insulin and Insulin Analogs and Risk of Cancer — Systematic Review and Meta-Analysis of Observational Studies
Current Drug Safety Proteomic Approaches for the Study of Transgelins as Tumor-associated Proteins and Potential Biomarkers
Current Proteomics Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation
Current Medicinal Chemistry Multifunctional Proteins in Tumorigenesis: Aminoacyl-tRNA Synthetases and Translational Components
Current Proteomics Management of Antineutrophil Cytoplasmic Antibody Associated Vasculitis
Current Immunology Reviews (Discontinued) The Chemopreventive and Chemotherapeutic Potentials of Tea Polyphenols
Current Pharmaceutical Biotechnology Possible Involvement of Angiogenesis in Chronic Liver Diseases: Interaction Among Renin-Angiotensin-Aldosterone System, Insulin Resistance and Oxidative Stress
Current Medicinal Chemistry ANTI-ADHESION Evolves To a Promising Therapeutic Concept in Oncology
Current Medicinal Chemistry Update on the Rheumatologic Manifestations of Malignancy
Current Cancer Therapy Reviews Crude Venom from Nematocysts of the Jellyfish Pelagia noctiluca as a Tool to Study Cell Physiology
Central Nervous System Agents in Medicinal Chemistry Peptides for Tumour Therapy and Diagnosis: Current Status and Future Directions
Current Medicinal Chemistry The Hedgehog Signaling Pathway as a Target for Anticancer Drug Discovery
Current Topics in Medicinal Chemistry Tumour-Derived Glutamate: Linking Aberrant Cancer Cell Metabolism to Peripheral Sensory Pain Pathways
Current Neuropharmacology Prognostic Parameters in Myeloid Malignancies in a Historical Context – From Microscopy to Individualized Medicine
Current Drug Targets Turner Syndrome : How Is It Made Up?
Current Genomics